Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis

Pediatric Research

Volumn 62, Issue 2, 2007, Pages 188-190

  Moonen, Rob M J ^a   Paulussen, Aimee D C ^b   Souren, Nicole Y P ^b   Kessels, Alfons G H ^b   Rubio Gozalbo, M Estela ^b   Villamor, Eduardo ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARBAMOYL PHOSPHATE SYNTHASE;

ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; NECROTIZING ENTEROCOLITIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

ARGININE; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); CASE-CONTROL STUDIES; ENTEROCOLITIS, NECROTIZING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34547626583     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3180a0324e     Document Type: Article

References (19)

1. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T 1978 Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187:1-7
2. Bell EF 2005 Preventing necrotizing enterocolitis: what works and how safe? Pediatrics 115:173-174
3. Caplan MS, Jilling T 2001 New concepts in necrotizing enterocolitis. Curr Opin Pediatr 13:111-115
4. Lee JS, Polin RA 2003 Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 8:449-459
5. Martin CR, Walker WA 2006 Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med 11:369-377
6. Reber KM, Nankervis CA 2004 Necrotizing enterocolitis: preventative strategies. Clin Perinatol 31:157-167
7. Reber KM, Nankervis CA, Nowicki PT 2002 Newborn intestinal circulation. Physiology and pathophysiology. Clin Perinatol 29:23-39
8. Walsh MC, Kliegman RM 1986 Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33:179-201
9. Upperman JS, Potoka D, Grishin A, Hackam D, Zamora R, Ford HR 2005 Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis. Semin Pediatr Surg 14:159-166
10. Amin HJ, Zamora SA, McMillan DD, Fick GH, Butzner JD, Parsons HG, Scott RB 2002 Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 140:425-431
11. Becker RM, Wu G, Galanko JA, Chen W, Maynor AR, Bose CL, Rhoads JM 2000 Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 137:785-793
12. Zamora SA, Amin HJ, McMillan DD, Kubes P, Fick GH, Butzner JD, Parsons HG, Scott RB 1997 Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr 131:226-232
13. Wu G, Jaeger LA, Bazer FW, Rhoads JM 2004 Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem 15:442-451
14. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML 2001 Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344:1832-1838
15. Summar ML, Hall L, Christman B, Barr F, Smith H, Kallianpur A, Brown N, Yadav M, Willis A, Eeds A, Cermak E, Summar S, Wilson A, Arvin M, Putnam A, Wills M, Cunningham G 2004 Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Mol Genet Metab 81:S12-S19
16. Treszl A, Tulassay T, Vasarhelyi B 2006 Genetic basis for necrotizing enterocolitis-risk factors and their relations to genetic polymorphisms. Front Biosci 11:570-580
17. Summar ML, Gainer JV, Pretorius M, Malave H, Harris S, Hall LD, Weisberg A, Vaughan DE, Christman BW, Brown NJ 2004 Relationship between carbamoylphosphate synthetase genotype and systemic vascular function. Hypertension 43:186-191
18. Heninger E, Treszl A, Kocsis I, Derfalvi B, Tulassay T, Vasarhelyi B 2002 Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 161:410-411
19. Treszl A, Heninger E, Kalman A, Schuler A, Tulassay T, Vasarhelyi B 2003 Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 38:1374-1378